Repeated VU0155069 Treatment Is Associated with Region- and Pathological Stage-Specific Dendritic Spine Remodeling in Female 3xTg-AD Mice

Background: Alzheimers disease (AD) is increasingly recognized as a disorder of synaptic integrity in which changes in dendritic spine abundance and morphology accompany progressive cognitive dysfunction. Phospholipase D1 (PLD1), a regulator of membrane trafficking and cytoskeletal signaling, is aberrantly elevated in AD-related pathological states (ADRD). Previous studies from our lab demonstrated that repeated VU0155069 treatment promotes functional resilience in female 3xTg-AD mice, including improvements in novel-object recognition, fear-conditioning performance, hippocampal LTP, later-stage LTP and LTD, selected neuropathological outcomes, and most importantly, CA1 spine integrity. Objective: To determine how this previously demonstrated functional resilience is represented structurally across cortical, hippocampal, and amygdalar circuits at earlier and later stages of AD-like pathology. Methods: Female 3xTg-AD mice received vehicle or VU0155069 at 1 mg/kg intraperitoneally every other day for one month beginning at 5 or 11 months of age, with Golgi-Cox analysis at 6 or 12 months, respectively. Age-matched vehicle-treated 3xTg-AD littermates served as the primary comparator for evaluating the structural response to pharmacological attenuation of disease-associated PLD1 signaling. Results: Auditory and visual cortical fields showed selective changes in spine-subtype distribution and morphometry. Hippocampal cornu ammonis (CA)2, CA3, and dentate gyrus (DG) exhibited distinct patterns involving spine abundance, density, and geometry, whereas the central, lateral, and basolateral amygdalar nuclei showed nucleus- and stage-dependent remodeling. Across the multiregional dataset, recurring responses comprised spine-subtype redistribution, changes in spine abundance, and morphometric remodeling rather than uniform structural rescue. Conclusions: VU0155069 engages circuit- and pathological stage-specific forms of dendritic spine remodeling across distributed recognition- and associative-memory networks.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-10-27
DOI
https://doi.org/10.64898/2026.10.26.762038
Primary Topic
Alzheimer's disease research and treatments
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Repeated VU0155069 Treatment Is Associated with Region- and Pathological Stage-Specific Dendritic Spine Remodeling in Female 3xTg-AD Mice

Karthik Ramaswamy, Chandramouli Natarajan, Balaji Krishnan, Sanjana Mohanty et al.
2 links
bioRxiv (Cold Spring Harbor Laboratory)
Alzheimer's disease research and treatments
preprint

Repeated VU0155069 Treatment Is Associated with Region- and Pathological Stage-Specific Dendritic Spine Remodeling in Female 3xTg-AD Mice

Karthik Ramaswamy, Chandramouli Natarajan, Balaji Krishnan, Sanjana Mohanty, Sarah Bosworth
preprint en

Abstract

Background: Alzheimers disease (AD) is increasingly recognized as a disorder of synaptic integrity in which changes in dendritic spine abundance and morphology accompany progressive cognitive dysfunction. Phospholipase D1 (PLD1), a regulator of membrane trafficking and cytoskeletal signaling, is aberrantly elevated in AD-related pathological states (ADRD). Previous studies from our lab demonstrated that repeated VU0155069 treatment promotes functional resilience in female 3xTg-AD mice, including improvements in novel-object recognition, fear-conditioning performance, hippocampal LTP, later-stage LTP and LTD, selected neuropathological outcomes, and most importantly, CA1 spine integrity. Objective: To determine how this previously demonstrated functional resilience is represented structurally across cortical, hippocampal, and amygdalar circuits at earlier and later stages of AD-like pathology. Methods: Female 3xTg-AD mice received vehicle or VU0155069 at 1 mg/kg intraperitoneally every other day for one month beginning at 5 or 11 months of age, with Golgi-Cox analysis at 6 or 12 months, respectively. Age-matched vehicle-treated 3xTg-AD littermates served as the primary comparator for evaluating the structural response to pharmacological attenuation of disease-associated PLD1 signaling. Results: Auditory and visual cortical fields showed selective changes in spine-subtype distribution and morphometry. Hippocampal cornu ammonis (CA)2, CA3, and dentate gyrus (DG) exhibited distinct patterns involving spine abundance, density, and geometry, whereas the central, lateral, and basolateral amygdalar nuclei showed nucleus- and stage-dependent remodeling. Across the multiregional dataset, recurring responses comprised spine-subtype redistribution, changes in spine abundance, and morphometric remodeling rather than uniform structural rescue. Conclusions: VU0155069 engages circuit- and pathological stage-specific forms of dendritic spine remodeling across distributed recognition- and associative-memory networks.

bioRxiv (Cold Spring Harbor Laboratory)
The University of Texas Medical Branch at Galveston (US)
Alzheimer's Association, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, National Institute on Aging
Good health and well-being
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon